Novel immunotherapies for breast cancer: Focus on 2023 findings

HR Lan, M Chen, SY Yao, JX Chen, KT Jin - International …, 2024 - Elsevier
Immunotherapy has emerged as a revolutionary approach in cancer therapy, and recent
advancements hold significant promise for breast cancer (BCa) management. Employing the …

Emerging roles of RNA binding proteins in intervertebral disc degeneration and osteoarthritis

W Li, XH Li, Y Gao, CJ Xiong, ZZ Tang - Orthopaedic Surgery, 2023 - Wiley Online Library
The etiology of intervertebral disc degeneration (IDD) and osteoarthritis (OA) is complex and
multifactorial. Both predisposing genes and environmental factors are involved in the …

New insights into the role of the CHI3L2 protein in invasive ductal breast carcinoma

A Rusak, E Kątnik, T Górnicki, C Schmuttermaier… - Scientific Reports, 2024 - nature.com
Chitinase-like proteins have multiple biological functions that promote tumor growth,
angiogenesis and metastasis. Expression of CHI3L2, which is similar in structure to CHI3L1 …

Target Ligand Separation and Identification of Isoforsythiaside as a Histone Lysine-Specific Demethylase 1 Covalent Inhibitor Against Breast Cancer Metastasis

M Gu, X Xu, X Wang, Y Wang, Y Zhao… - Journal of Medicinal …, 2024 - ACS Publications
Histone lysine-specific demethylase 1 (LSD1) is hyperactive in breast cancer, which is
associated with the metastasis of the tumor. Current irreversible LSD1 inhibitors are all …

Glucocorticoid receptor: a harmonizer of cellular plasticity in breast cancer—directs the road towards therapy resistance, metastatic progression and recurrence

D Thakur, D Sengupta, E Mahapatra, S Das… - Cancer and Metastasis …, 2024 - Springer
Recent therapeutic advances have significantly uplifted the quality of life in breast cancer
patients, yet several impediments block the road to disease-free survival. This involves …

[HTML][HTML] Impact of RBMS 3 Progression on Expression of EMT Markers

T Górnicki, J Lambrinow, M Mrozowska… - Cells, 2024 - mdpi.com
Epithelial-to-mesenchymal transition (EMT) is a complex cellular process that allows cells to
change their phenotype from epithelial to mesenchymal-like. Type 3 EMT occurs during …

[HTML][HTML] RNA-Binding Proteins in Breast Cancer: Biological Implications and Therapeutic Opportunities

S Wang, H Sun, G Chen, C Wu, B Sun, J Lin… - Critical Reviews in …, 2024 - Elsevier
RNA-binding proteins (RBPs) refer to a class of proteins that participate in alternative
splicing, RNA stability, polyadenylation, localization and translation of RNAs, thus regulating …

Inhibition of CHI3L1 decreases N-cadherin and VCAM-1 levels in glioblastoma

A Rusak, M Gąsior-Głogowska, A Sargenti… - Pharmacological …, 2024 - Springer
Abstract Background The protein CHI3L1 contributes to cancer development by several
mechanisms, including stimulation of angiogenesis and invasion as well as …

Tumor suppressor function of RBMS3 overexpression in EOC associated with immune cell infiltration

T Yin, Y Zhang, Y Zhao, X Zhang, S Han, Y Wang… - Heliyon, 2024 - cell.com
Objectives Epithelial ovarian cancer (EOC) is considered to be a prevalent female
malignancy with both high incidence and mortality. It is reported that RNA-binding protein 3 …

[HTML][HTML] Metformin-induced RBMS3 expression enhances ferroptosis and suppresses ovarian cancer progression

Y Zhao, Y Wang, X Zhang, S Han, B Yang - Reproductive Biology, 2025 - Elsevier
Metformin (Met), a widely used type II diabetes medication, has shown anti-cancer
properties in various cancers. RBMS3 is a tumor suppressor implicated in several cancers …